“…This lineage was initially identified in low proportions as a minor clone in Greece and Korea, with the latter being associated with bla VIM-2 ; subsequent reports have documented clonal spread. These include a massive and persistent colonization of a dental care unit waterline in a University Hospital in France [33], isolates from children with bacteremia in Mexico [10], extensively drug-resistant clinical isolates from the United States [9], the Philippines [34], and Brazil [8], and intestinal colonization and environmental samples from a long-term care facility in France [32]. ST309 clones are reported to carry several acquired resistance genes in class one integrons, including ESBLs (bla GES-19, -20, -26 ), carbapenemases (bla VIM-2 and bla IMP-15 ), aminoglycoside-modifying enzymes (aadA1, aacA4, aac(6 ′ )-Il and aac(6 ′ )-33), and fluoroquinolone resistance genes (qnrVC1), among others [8].…”